Shanghai's Cascade gets $72M to pursue MASH, obesity and diabetes drugs
Shanghai's Cascade gets $72M to pursue MASH, obesity and diabetes drugs
Body unavailable. Use the original source.
Shanghai's Cascade gets $72M to pursue MASH, obesity and diabetes drugs
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.